We are live on ! Find out more
BBA

BLB&B Advisors Portfolio holdings

AUM $2.73B Turnover 8.25%
1-Year Est. Return 25.76%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+25.76%
3 Year Est. Return
+71.58%
5 Year Est. Return
+74.54%
10 Year Est. Return
+243.21%
AUM
$649M
AUM Growth
+$46.5M
Cap. Flow
+$22.6M
Cap. Flow %
3.48%
Top 10 Hldgs %
22.74%
Holding
307
New
27
Increased
125
Reduced
107
Closed
5
Avg Time Held
2.9 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
3.5 years

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.13M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.66M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$2.29M
4
SCHM icon
Schwab US Mid-Cap ETF
SCHM
+$1.66M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.4M

Top Sells

Rank Stock Value
1
DD icon
Du Pont De Nemours E I
DD
+$5.78M
2
SYY icon
Sysco
SYY
+$1.79M
3
JCI icon
Johnson Controls International
JCI
+$1.04M
4
BA icon
Boeing
BA
+$428K
5
MDLZ icon
Mondelez International
MDLZ
+$394K

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.34%
2 Technology 13.71%
3 Healthcare 11.48%
4 Industrials 11.12%
5 Financials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VWO icon
1
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$18M 2.77%
412,996
+31,741
+8% +$1.37M
2013 Q2
17 quarters
JNJ icon
2
Johnson & Johnson
JNJ
$610B
$16.6M 2.56%
127,754
+1,020
+0.8% +$135K
2013 Q2
17 quarters
VEA icon
3
Vanguard FTSE Developed Markets ETF
VEA
$228B
$15.3M 2.36%
353,282
+33,058
+10% +$1.4M
2013 Q4
15 quarters
IJR icon
4
iShares Core S&P Small-Cap ETF
IJR
$103B
$15.3M 2.35%
205,707
+32,744
+19% +$2.29M
2015 Q1
10 quarters
INTC icon
5
Intel
INTC
$504B
$15.2M 2.34%
398,204
+836
+0.2% +$29.7K
2013 Q2
17 quarters
SCHM icon
6
Schwab US Mid-Cap ETF
SCHM
$14.6B
$14.4M 2.21%
860,916
+102,024
+13% +$1.66M
2013 Q2
17 quarters
XOM icon
7
ExxonMobil
XOM
$718B
$14.2M 2.18%
172,694
+2,906
+2% +$231K
2013 Q2
17 quarters
SPY icon
8
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$13.1M 2.02%
52,187
+10,805
+26% +$2.66M
2015 Q1
10 quarters
MSFT icon
9
Microsoft
MSFT
$4.01T
$12.9M 1.99%
173,106
-1,482
-0.8% -$108K
2013 Q2
17 quarters
PG icon
10
Procter & Gamble
PG
$365B
$12.7M 1.96%
139,695
+1,237
+0.9% +$113K
2013 Q2
17 quarters
JPM icon
11
JPMorgan Chase
JPM
$891B
$12.1M 1.87%
127,147
+1,782
+1% +$164K
2013 Q2
17 quarters
GLW icon
12
Corning
GLW
$119B
$11.9M 1.83%
396,990
-1,335
-0.3% -$39.5K
2013 Q2
17 quarters
MMM icon
13
3M
MMM
$85.3B
$11.9M 1.83%
67,609
+894
+1% +$155K
2013 Q2
17 quarters
VZ icon
14
Verizon
VZ
$184B
$10.6M 1.64%
214,593
+564
+0.3% +$26.5K
2013 Q2
17 quarters
IBM icon
15
IBM
IBM
$221B
$10.5M 1.62%
76,038
+3,521
+5% +$491K
2013 Q2
17 quarters
T icon
16
AT&T
T
$161B
$10M 1.55%
339,320
+11,274
+3% +$320K
2013 Q2
17 quarters
AAPL icon
17
Apple
AAPL
$4.99T
$9.78M 1.51%
253,816
+1,848
+0.7% +$71.7K
2013 Q2
17 quarters
GE icon
18
GE Aerospace
GE
$324B
$9.41M 1.45%
81,175
+4,737
+6% +$573K
2013 Q2
17 quarters
PFE icon
19
Pfizer
PFE
$168B
$9.03M 1.39%
266,678
-9,599
-3% -$309K
2013 Q2
17 quarters
CVX icon
20
Chevron
CVX
$430B
$8.59M 1.32%
73,081
+760
+1% +$83K
2013 Q2
17 quarters
PNC icon
21
PNC Financial Services
PNC
$85.7B
$8.02M 1.24%
59,496
-62
-0.1% -$7.96K
2013 Q2
17 quarters
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.13T
$7.57M 1.17%
41,286
+2,045
+5% +$361K
2014 Q1
14 quarters
CSCO icon
23
Cisco
CSCO
$433B
$7.53M 1.16%
224,013
+676
+0.3% +$21.5K
2013 Q2
17 quarters
MRK icon
24
Merck
MRK
$358B
$7.3M 1.12%
119,416
+842
+0.7% +$51K
2013 Q2
17 quarters
DD icon
25
DuPont de Nemours
DD
$17.8B
$7.11M 1.09%
40,528
+36,757
+975% +$6.13M
2013 Q2
17 quarters
1
2 3 4 5

Similar funds

MAS
Meeder Advisory Services Dublin, Ohio $2.73B AUM 32.21% 1-Year Est. Return
ACM
Analog Century Management New York $2.73B AUM 298.81% 1-Year Est. Return
CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 16.93% 1-Year Est. Return
LIM
Leavell Investment Management Mobile, Alabama $2.74B AUM 26.51% 1-Year Est. Return
SIG
Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return
GXJ
Global X Japan Chiyoda-Ku, Tokyo, Japan $2.72B AUM 45.88% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 2.36% 1-Year Est. Return

BLB&B Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, BLB&B Advisors held 307 positions worth $649M, up 7.7% from $603M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

BLB&B Advisors deployed $22.6M of net new capital in Q3 2017, opening 27 new positions and adding to 125 existing holdings. Its largest new stake was AstraZeneca: 11,731 shares worth $795K.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Sysco, an estimated $1.79M trimmed.

  • BLB&B Advisors's largest Q3 2017 buy was AstraZeneca: 11,731 shares worth $795K.
  • BLB&B Advisors added most to DuPont de Nemours in Q3 2017, an estimated $6.13M increase.
  • BLB&B Advisors's biggest Q3 2017 reduction was Sysco, cutting an estimated $1.79M.
  • BLB&B Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $5.78M.
  • BLB&B Advisors's ten largest holdings make up 23% of its $649M portfolio in Q3 2017.
  • BLB&B Advisors opened 27 new positions and closed 5 in Q3 2017.
  • BLB&B Advisors's portfolio value rose 7.7% quarter-over-quarter to $649M.

Based on BLB&B Advisors's 13F filing for Q3 2017, filed 16 Oct 2017.